VVOS (Vivos Therapeutics, Inc) Market Value to Book Value Ratio

Vivos Therapeutics (VVOS) is expanding its network of partnerships with private dental practices to implement non-surgical apnea therapy techniques. Business revenues are based on the sale of advanced maxillofacial correction systems, where the indicator stands at -0.39. This chart of the market price illustrates the dynamics of a company that is displacing cumbersome alternatives through unique regulatory approvals and technological superiority within its niche.

This indicator serves as a baseline filter for assessing whether an asset is overbought or undervalued. The metric compares current market value with net assets, identifying the risk of a "value trap" during a prolonged decline in quotes. By analyzing the premium of market value over book capital, an investor determines the business's resilience to industry cycles. For Vivos Therapeutics (VVOS), this confirms the value of its intellectual capital. A stable staff of R&D specialists and engineers provides fundamental support for the company's valuation.